Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.45), $0.03 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.